| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.41▼ | 1.42▼ | 1.42▼ | 1.45▼ | 1.39▲ |
| MA10 | 1.42▼ | 1.42▼ | 1.41▲ | 1.44▼ | 1.36▲ |
| MA20 | 1.42▼ | 1.41▲ | 1.43▼ | 1.40▲ | 1.42▼ |
| MA50 | 1.42▼ | 1.46▼ | 1.45▼ | 1.36▲ | 2.34▼ |
| MA100 | 1.41▲ | 1.45▼ | 1.41▼ | 1.44▼ | 2.02▼ |
| MA200 | 1.43▼ | 1.41▲ | 1.41▼ | 2.21▼ | 1.47▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.001▼ | 0.004▲ | 0.000▲ | -0.001▼ | 0.059▲ |
| RSI | 43.911▼ | 46.196▼ | 45.014▼ | 50.370▲ | 39.248▼ |
| STOCH | 30.556 | 43.939 | 75.694 | 61.462 | 54.451 |
| WILL %R | -83.333▼ | -63.636 | -29.167 | -62.712 | -41.304 |
| CCI | -91.525 | -80.460 | 48.470 | -9.242 | 60.819 |
|
Thursday, April 16, 2026 06:26 AM
Detailed price information for Akebia Therapeutics (AKBA-Q) from The Globe and Mail including charting and trades.
|
|
Thursday, April 16, 2026 06:26 AM
Detailed price information for Akebia Therapeutics (AKBA-Q) from The Globe and Mail including charting and trades.
|
|
Monday, April 13, 2026 05:01 AM
Akebia Therapeutics ®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced the first participants have been ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 20/04/26 | 1.405 | 1.435 | 1.405 | 1.41 | 801,305 |
| 17/04/26 | 1.38 | 1.445 | 1.325 | 1.405 | 4,029,266 |
| 16/04/26 | 1.54 | 1.56 | 1.35 | 1.35 | 5,186,329 |
| 15/04/26 | 1.57 | 1.595 | 1.53 | 1.55 | 2,011,145 |
| 14/04/26 | 1.48 | 1.56 | 1.47 | 1.56 | 2,224,372 |
| 13/04/26 | 1.40 | 1.47 | 1.39 | 1.47 | 1,731,936 |
| 10/04/26 | 1.41 | 1.46 | 1.38 | 1.40 | 2,051,166 |
| 09/04/26 | 1.42 | 1.45 | 1.41 | 1.41 | 1,248,314 |
| 08/04/26 | 1.41 | 1.47 | 1.40 | 1.43 | 2,500,698 |
| 07/04/26 | 1.32 | 1.39 | 1.30 | 1.38 | 2,352,039 |
|
|
||||
|
|
||||
|
|